ROBERT DAIBER: Open Payments
NPI 1922147818 · MAUMEE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$475 in 19 payments from 10 companies in 2025. Trend: 2023 $58 · 2024 $464 · 2025 $475
Food & beverage: $363Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $131 |
| Braeburn Inc. | 4 | $85 |
| Vanda Pharmaceuticals Inc. | 2 | $53 |
| ABBVIE INC. | 3 | $53 |
| Alkermes, Inc. | 2 | $44 |
| Lundbeck LLC | 2 | $34 |
| Indivior Inc. | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: BRIXADI, FANAPT, VRAYLAR, REXULTI, SUBLOCADE, VIVITROL, AUSTEDO XR, ARISTADA.
Industry payments across OH — which companies pay providers there.
